Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery

• Tove Lekva ,

  * E-mail: tove.lekva@medisin.uio.no

  Affiliations Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway, Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Jens Petter Berg,

  Affiliations Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway, Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway

  ⨯
• Ansgar Heck,

  Affiliations Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Stine Lyngvi Fougner,

  Affiliation Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

  ⨯
• Ole Kristoffer Olstad,

  Affiliation Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway

  ⨯
• Geir Ringstad,

  Affiliation Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway

  ⨯
• Jens Bollerslev,

  Affiliations Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Thor Ueland

  Affiliations Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯